Differenzierung und Aktivierung von Immunzellen im Tumormilieu - Analyse der Rolle von Laktat als Immunmodulator in vitro und in vivo

• Antragstellerinnen: Dr. Elisabeth Kohl; Professorin Dr. Marina P. Kreutz; Dr. Gudrun Köhl
• Fachliche Zuordnung: Hämatologie, Onkologie
• Förderung: Förderung von 2011 bis 2018
• Projektkennung: Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 190230491

• Erstellungsjahr: 2019

Zusammenfassung der Projektergebnisse

The tumor microenvironment modulates the activation of infiltrating cells and thereby regulates the balance between immune response and tolerance. The main findings of this project are that tumorderived lactic acid can suppress T and NK cells in vitro and in vivo which adds another piece to the tumor immune suppression puzzle. Based on these data we speculated that tumor derived lactic acid may limit the efficacy of checkpoint therapy. We demonstrated in several publications that the NSAID diclofenac blocks lactate secretion while preserving T cell effector functions which may result in a better response to checkpoint therapy. Our very recent data support this conclusion as we were able to show that diclofenac can improve checkpoint therapy in a murine breast carcinoma model. And we hope that these data will help us to get funding to confirm our findings in a clinical trial.

Projektbezogene Publikationen (Auswahl)

• (2012). Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation. Int J Cancer. Aug1;131(3):633-40
  Mendler AN, Hu B, Prinz PU, Kreutz M, Gottfried E, Noessner E
  (Siehe online unter https://doi.org/10.1002/ijc.26410)
• (2013). Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Int J Cancer. Feb 15;132(4):843-53
  Chirasani SR, Leukel P, Gottfried E, Hochrein J, Stadler K, Neumann B, Oefner PJ, Gronwald W, Bogdahn U, Hau P, Kreutz M, Grauer OM
  (Siehe online unter https://doi.org/10.1002/ijc.27712)
• (2013). Distinct metabolic differences between various human cancer and primary cells. Electrophoresis. 2013 Jul 16
  Dettmer K, Vogl FC, Ritter AP, Zhu W, Nürnberger N, Kreutz M, Oefner PJ, Gronwald W, Gottfried E
  (Siehe online unter https://doi.org/10.1002/elps.201300228)
• (2013). New Aspects of an Old Drug - Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells. PLoS One. 2013 Jul 9;8(7)
  Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M
  (Siehe online unter https://doi.org/10.1371/journal.pone.0066987)
• (2014). Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch. Sep;465(3):299-312
  Krupar R, Robold K, Gaag D, Spanier G, Kreutz M, Renner K, Hellerbrand C, Hofstaedter F, Bosserhoff AK
  (Siehe online unter https://doi.org/10.1007/s00428-014-1630-6)
• (2015). Lactic acid delays the inflammatory response of human monocytes. Biochem Biophys Res Commun. Feb 13;457(3):412-8
  Peter K, Rehli M, Singer K, Renner-Sattler K, Kreutz M
  (Siehe online unter https://doi.org/10.1016/j.bbrc.2015.01.005)
• (2016) LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. Cell Metab. Nov 8;24(5):657-671
  Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M
  (Siehe online unter https://doi.org/10.1016/j.cmet.2016.08.011)
• (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2. Cell Cycle. Jul 2;15(13):1755-66
  Seliger C, Meyer AL, Renner K, Leidgens V, Moeckel S, Jachnik B, Dettmer K, Tischler U, Gerthofer V, Rauer L, Uhl M, Proescholdt M, Bogdahn U, Riemenschneider MJ, Oefner PJ, Kreutz M, Vollmann- Zwerenz A, Hau P
  (Siehe online unter https://doi.org/10.1080/15384101.2016.1186316)
• (2016). Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells. Oncoimmunology. Jun 10;5(8):e1184802
  Henrich FC, Singer K, Poller K, Bernhardt L, Strobl CD, Limm K, Ritter AP, Gottfried E, Völkl S, Jacobs B, Peter K, Mougiakakos D, Dettmer K, Oefner PJ, Bosserhoff AK, Kreutz MP, Aigner M, Mackensen A
  (Siehe online unter https://doi.org/10.1080/2162402X.2016.1184802)
• (2017). Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment. Front Immunol. Mar 8;8:248. Review 2016
  Renner K, Singer K, Koehl GE, Geissler EK, Peter K, Siska PJ, Kreutz M
  (Siehe online unter https://doi.org/10.3389/fimmu.2017.00248)
• (2018) Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism. J BiolChem. Oct 12;293(41):15947-15961
  Ždralević M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G,Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouysségur J, Kreutz M
  (Siehe online unter https://doi.org/10.1074/jbc.RA118.004180)
• (2018) Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma., Cancer Lett. Nov 24; 442:453-463
  Brummer C, Faerber S, Bruss C, Blank C, Lacroix R, Haferkamp S, Herr W, Kreutz M, Renner K
  (Siehe online unter https://doi.org/10.1016/j.canlet.2018.11.018)
• (2018). Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma. Int J Mol Sci. Aug 31;19(9)
  Gerthofer V, Kreutz M, Renner K, Jachnik B, Dettmer K, Oefner P, Riemenschneider MJ, Proescholdt M, Vollmann-Zwerenz A, Hau P, Seliger C
  (Siehe online unter https://doi.org/10.3390/ijms19092586)
• (2018). Tumor immunoevasion via acidosis dependent induction of regulatory tumor-associated macrophages. Nat Immunol. Dec; 19(12):1319-1329
  Bohn T., Rapp S., Luther N., Klein M., Bruehl T.,Kojima N Lopez P:A., Hahlbrock J., Muth S., Endo S., Pektor S., Brand A., Renner K., Popp V., Gerlach K., Vogel D., Lueckel C., Arnold-Schild D., Pouyssegur J., Kreutz M., Huber M., KoenigJ., Weigmann B., Probst H., Stebut E., Becker C., Schild H., Schmitt E., Bopp T.
  (Siehe online unter https://doi.org/10.1038/s41590-018-0226-8)
• Combined metabolic targeting with metformin and the NSAIDs diflunisal and diclofenac induces apoptosis in acute myeloid leukemia cells. Front Pharmacol. 2018 Nov 2; 9:1258
  Renner K., SeilbeckA., Kauer N., Ugele I., Siska P.J., Brummer C., Bruss C., Decking S., FanteM., Schmid A., Hammon K., Singer K., Klobuch S., Thomas S., Gottfried E., Peter K., Kreutz M.
  (Siehe online unter https://doi.org/10.3389/fphar.2018.01258)